-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On NRX Pharmaceuticals with Buy Rating, Announces Price Target of $18

Benzinga·04/02/2025 13:43:17
Listen to the news
BTIG analyst Thomas Schrader initiates coverage on NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy rating and announces Price Target of $18.